Stocks
Agios Pharmaceuticals (AGIO) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -6.11 | -7.43 | -2.36 | -1.39 | -1.39 | 0.36 | ||
| Changes by years, y/y, % | +20% | +22% | -68% | -41% | +0% | -22.9% | |||
Agios Pharmaceuticals. EV/EBITDA
Agios Pharmaceuticals. EV/EBITDA, changes, %
Agios Pharmaceuticals (AGIO) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -1.15 | -1.39 | -2.88 | -4.87 | 2.26 | 0.36 | |
| Changes by years, y/y, % | -52% | -14% | +333% | +248% | -297% | |||
| Changes by quarters, q/q, % | -18% | +21% | +107% | +69% | -146% | |||
